Nanobiotechnology for the Therapeutic Targeting of Cancer Cells in Blood

[1]  John W. Park,et al.  Circulating Tumor Cells , 2017, Methods in Molecular Biology.

[2]  W. Han,et al.  Drug response of captured BT20 cells and evaluation of circulating tumor cells on a silicon nanowire platform. , 2015, Biosensors & bioelectronics.

[3]  Klaus Pantel,et al.  Biology, detection, and clinical implications of circulating tumor cells , 2014, EMBO molecular medicine.

[4]  Kyung-Ja Cho,et al.  Epithelial-Mesenchymal Transition , 2014, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[5]  A. Atala.  Re: TRAIL-Coated Leukocytes that Kill Cancer Cells in the Circulation , 2014 .

[6]  P. Charoenphol,et al.  Plasma Protein Corona Modulates the Vascular Wall Interaction of Drug Carriers in a Material and Donor Specific Manner , 2014, PloS one.

[7]  Sridhar Ramaswamy,et al.  Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis , 2014, Cell.

[8]  Kenji Yasuda,et al.  Development of On-Chip Multi-Imaging Flow Cytometry for Identification of Imaging Biomarkers of Clustered Circulating Tumor Cells , 2014, PloS one.

[9]  Martin G Pomper,et al.  State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[10]  R. Hynes,et al.  Platelets guide the formation of early metastatic niches , 2014, Proceedings of the National Academy of Sciences.

[11]  Sridhar Ramaswamy,et al.  Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility , 2014, Science.

[12]  P. Decuzzi,et al.  Lipid-polymer nanoparticles encapsulating curcumin for modulating the vascular deposition of breast cancer cells. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[13]  Richard J. Lee,et al.  Circulating tumour cells—monitoring treatment response in prostate cancer , 2014, Nature Reviews Clinical Oncology.

[14]  X. Ji,et al.  Doxorubicin-loaded silicon nanowires for the treatment of drug-resistant cancer cells. , 2014, Biomaterials.

[15]  Ben S. Wittner,et al.  Abstract 4832: Isolation and molecular characterization of circulating melanoma cells , 2014 .

[16]  K. Braeckmans,et al.  Merging the Best of Both Worlds: Hybrid Lipid‐Enveloped Matrix Nanocomposites in Drug Delivery , 2014 .

[17]  Aviv Regev,et al.  Whole exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer , 2014, Nature Biotechnology.

[18]  J. C. Love,et al.  Functional analysis of single cells identifies a rare subset of circulating tumor cells with malignant traits. , 2014, Integrative biology : quantitative biosciences from nano to macro.

[19]  Xiaoyang Xu,et al.  Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. , 2014, Advanced drug delivery reviews.

[20]  N. Steinmetz,et al.  Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice. , 2014, Virology.

[21]  Chin Chun Ooi,et al.  Isolation and mutational analysis of circulating tumor cells from lung cancer patients with magnetic sifters and biochips. , 2014, Lab on a chip.

[22]  Yoav D Livney,et al.  Rationally designed nanovehicles to overcome cancer chemoresistance. , 2013, Advanced drug delivery reviews.

[23]  M. Ferrari,et al.  High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics. , 2013, ACS nano.

[24]  M. Nieto.  Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells , 2013, Science.

[25]  K. Pantel,et al.  Presence of EpCAM‐positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma , 2013, International journal of cancer.

[26]  M. King,et al.  Human fucosyltransferase 6 enables prostate cancer metastasis to bone , 2013, British Journal of Cancer.

[27]  R. Jain,et al.  Strategies for advancing cancer nanomedicine. , 2013, Nature materials.

[28]  Stefan Tenzer,et al.  Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. , 2013, Nature nanotechnology.

[29]  Haifeng Zhao,et al.  Epithelial–mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease , 2013, Cell Death and Disease.

[30]  Daniel F. Hayes,et al.  Sensitive capture of circulating tumour cells by functionalised graphene oxide nanosheets , 2013, Nature nanotechnology.

[31]  Z. Werb,et al.  Circulating Tumor Cells , 2013, Science.

[32]  K. Pantel,et al.  Capture of viable circulating tumor cells in the liver of colorectal cancer patients. , 2013, Clinical chemistry.

[33]  O. Eniola-Adefeso,et al.  Effect of PEGylation on ligand-based targeting of drug carriers to the vascular wall in blood flow. , 2013, Langmuir : the ACS journal of surfaces and colloids.

[34]  R. Hesketh,et al.  Barriers to drug delivery in interventional oncology. , 2013, Journal of vascular and interventional radiology : JVIR.

[35]  M. Sperandio,et al.  The molecular basis of leukocyte recruitment and its deficiencies. , 2013, Molecular immunology.

[36]  Ronnie H. Fang,et al.  Surface Functionalization of Gold Nanoparticles with Red Blood Cell Membranes , 2013, Advanced materials.

[37]  R. Jain.  Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  N. Steinmetz,et al.  Shape matters: the diffusion rates of TMV rods and CPMV icosahedrons in a spheroid model of extracellular matrix are distinct. , 2013, Biomaterials science.

[39]  Tim Holland-Letz,et al.  Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay , 2013, Nature Biotechnology.

[40]  Wei Yin,et al.  The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis , 2013, Science Translational Medicine.

[41]  S. Miyano,et al.  Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis. , 2013, Cancer research.

[42]  Gregory P Howard,et al.  A platelet-mimetic paradigm for metastasis-targeted nanomedicine platforms. , 2013, Biomacromolecules.

[43]  C. Lim,et al.  Isolation and retrieval of circulating tumor cells using centrifugal forces , 2013, Scientific Reports.

[44]  Crispin R Dass,et al.  Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems , 2013, The Journal of pharmacy and pharmacology.

[45]  Sridhar Ramaswamy,et al.  Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition , 2013, Science.

[46]  Chuanbin Mao,et al.  Bacteriophage bionanowire as a carrier for both cancer-targeting peptides and photosensitizers and its use in selective cancer cell killing by photodynamic therapy. , 2013, Small.

[47]  B. Cieply,et al.  Mechanisms that link the oncogenic epithelial–mesenchymal transition to suppression of anoikis , 2013, Journal of Cell Science.

[48]  Michael D. Henry,et al.  Resistance to Fluid Shear Stress Is a Conserved Biophysical Property of Malignant Cells , 2012, PloS one.

[49]  J. Lévesque,et al.  Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance , 2012, Nature Medicine.

[50]  Richard O Hynes,et al.  The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. , 2012, Cancer discovery.

[51]  Liangfang Zhang,et al.  Erythrocyte‐Inspired Delivery Systems , 2012, Advanced healthcare materials.

[52]  Minseok S Kim,et al.  Highly efficient assay of circulating tumor cells by selective sedimentation with a density gradient medium and microfiltration from whole blood. , 2012, Analytical chemistry.

[53]  Tao Wang,et al.  Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast Cancer , 2012, Clinical Cancer Research.

[54]  T. Teknos,et al.  Multiparameter Analysis, including EMT Markers, on Negatively Enriched Blood Samples from Patients with Squamous Cell Carcinoma of the Head and Neck , 2012, PloS one.

[55]  M. King,et al.  Adhesion receptors as therapeutic targets for circulating tumor cells , 2012, Front. Oncol..

[56]  Cynthia A. Reinhart-King,et al.  Inducing Apoptosis in Rolling Cancer Cells: A Combined Therapy with Aspirin and Immobilized TRAIL and E-Selectin , 2012, Molecular pharmaceutics.

[57]  D. Astruc,et al.  Docetaxel Nanotechnology in Anticancer Therapy , 2012, ChemMedChem.

[58]  R. Fan,et al.  Nanowire substrate-based laser scanning cytometry for quantitation of circulating tumor cells. , 2012, Nano letters.

[59]  Boran Cheng,et al.  Electrospun TiO2 Nanofiber‐Based Cell Capture Assay for Detecting Circulating Tumor Cells from Colorectal and Gastric Cancer Patients , 2012, Advanced materials.

[60]  Sridhar Ramaswamy,et al.  RNA sequencing of pancreatic circulating tumour cells implicates WNT signaling in metastasis , 2012, Nature.

[61]  B. Greene,et al.  Microtube device for selectin-mediated capture of viable circulating tumor cells from blood. , 2012, Clinical chemistry.

[62]  A. Żaczek,et al.  Epithelial-Mesenchymal Transition: A Hallmark in Metastasis Formation Linking Circulating Tumor Cells and Cancer Stem Cells , 2012, Pathobiology.

[63]  Caroline Dive,et al.  Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[64]  Peter Kuhn,et al.  Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors , 2012, Physical biology.

[65]  K. Pantel,et al.  Circulating tumor cells and circulating tumor DNA. , 2012, Annual review of medicine.

[66]  H. Rammensee,et al.  Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells. , 2012, Cancer research.

[67]  M. King,et al.  Glycomechanics of the Metastatic Cascade: Tumor Cell–Endothelial Cell Interactions in the Circulation , 2012, Annals of Biomedical Engineering.

[68]  K. Ley,et al.  Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow. , 2011, Blood.

[69]  M. Ziman.  Circulating Melanoma Cells , 2011 .

[70]  Jens Ducrée,et al.  Platelet Adhesion and Degranulation Induce Pro-Survival and Pro-Angiogenic Signalling in Ovarian Cancer Cells , 2011, PloS one.

[71]  D. Planchard,et al.  Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer , 2011, British Journal of Cancer.

[72]  Robert A. Weinberg,et al.  Tumor Metastasis: Molecular Insights and Evolving Paradigms , 2011, Cell.

[73]  Richard O Hynes,et al.  Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. , 2011, Cancer cell.

[74]  Jesse V Jokerst,et al.  Nanoparticle PEGylation for imaging and therapy. , 2011, Nanomedicine.

[75]  Ronnie H. Fang,et al.  Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform , 2011, Proceedings of the National Academy of Sciences.

[76]  Andrew J Armstrong,et al.  Angiogenesis , Metastasis , and the Cellular Microenvironment Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers , 2011 .

[77]  Y. Assaraf,et al.  Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance. , 2011, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[78]  Jaap M. J. den Toonder,et al.  Circulating tumor cells: the Grand Challenge. , 2011, Lab on a chip.

[79]  Mehmet Toner,et al.  Circulating tumor cells: approaches to isolation and characterization , 2011, The Journal of cell biology.

[80]  Iseult Lynch,et al.  Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. , 2011, Journal of the American Chemical Society.

[81]  M. L. Blair,et al.  Suppression of prostate cancer cell rolling and adhesion to endothelium by 1α,25-dihydroxyvitamin D3. , 2011, The American journal of pathology.

[82]  Laurie J. Gay,et al.  Contribution of platelets to tumour metastasis , 2011, Nature Reviews Cancer.

[83]  K. Mohammad,et al.  TGF-beta-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases. , 2011, Cancer research.

[84]  M. King,et al.  Knockdown of fucosyltransferase III disrupts the adhesion of circulating cancer cells to E-selectin without affecting hematopoietic cell adhesion. , 2010, Carbohydrate research.

[85]  Jim E Riviere,et al.  An index for characterization of nanomaterials in biological systems. , 2010, Nature nanotechnology.

[86]  J. Rhodes,et al.  Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis , 2010, Molecular Cancer.

[87]  M. King,et al.  Use of naturally occurring halloysite nanotubes for enhanced capture of flowing cells. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[88]  H. Komatsu.  [Antibody therapy in cancer]. , 2010, Nihon rinsho. Japanese journal of clinical medicine.

[89]  D. Salomon,et al.  Novel and simple loading procedure of cisplatin into liposomes and targeting tumor endothelial cells. , 2010, International journal of pharmaceutics.

[90]  M. Quinn,et al.  Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer. , 2010, Current cancer drug targets.

[91]  Mehmet Toner,et al.  Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate Cancer , 2010, Science Translational Medicine.

[92]  Vladimir R Muzykantov,et al.  Drug delivery by red blood cells: vascular carriers designed by mother nature , 2010, Expert opinion on drug delivery.

[93]  M Ferrari,et al.  Size and shape effects in the biodistribution of intravascularly injected particles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[94]  Pakatip Ruenraroengsak,et al.  Nanosystem drug targeting: Facing up to complex realities. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[95]  Marina A Dobrovolskaia,et al.  Nanoparticles and the immune system. , 2010, Endocrinology.

[96]  U. Schumacher,et al.  E-/P-selectins and colon carcinoma metastasis: first in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung , 2009, British Journal of Cancer.

[97]  Alexander Gaitanis,et al.  Liposomal doxorubicin and nab-paclitaxel: nanoparticle cancer chemotherapy in current clinical use. , 2010, Methods in molecular biology.

[98]  Larry Norton,et al.  Tumor Self-Seeding by Circulating Cancer Cells , 2009, Cell.

[99]  Sei-Young Lee,et al.  Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows , 2009, Nanotechnology.

[100]  Jamison J. Grailer,et al.  L-selectin: role in regulating homeostasis and cutaneous inflammation. , 2009, Journal of dermatological science.

[101]  K. Pienta,et al.  Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking , 2009, Proceedings of the National Academy of Sciences.

[102]  David J. Sherman,et al.  Three-dimensional nanostructured substrates toward efficient capture of circulating tumor cells. , 2009, Angewandte Chemie.

[103]  R. Kimmig,et al.  Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer , 2009, Breast Cancer Research.

[104]  Mauro Ferrari,et al.  Design of bio-mimetic particles with enhanced vascular interaction. , 2009, Journal of biomechanics.

[105]  Konstantinos Konstantopoulos,et al.  Cancer cells in transit: the vascular interactions of tumor cells. , 2009, Annual review of biomedical engineering.

[106]  Tanja Fehm,et al.  Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients , 2009, Breast Cancer Research.

[107]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[108]  J. Liesveld,et al.  Delivery of apoptotic signal to rolling cancer cells: A novel biomimetic technique using immobilized TRAIL and E‐selectin , 2009, Biotechnology and bioengineering.

[109]  J. Pollard,et al.  Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.

[110]  I. Fichtner,et al.  Inhibition of metastasis in a murine 4T1 breast cancer model by liposomes preventing tumor cell-platelet interactions , 2009, Clinical & Experimental Metastasis.

[111]  Sabine Kasimir-Bauer,et al.  Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies , 2009, Breast Cancer Research and Treatment.

[112]  S. Wang,et al.  The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway , 2008, Oncogene.

[113]  J. Siddiqui,et al.  Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin. , 2008, Glycobiology.

[114]  K. Pienta,et al.  Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer , 2008, Clinical Cancer Research.

[115]  M. King,et al.  Platelet adhesive dynamics. Part I: characterization of platelet hydrodynamic collisions and wall effects. , 2008, Biophysical journal.

[116]  Mauro Ferrari,et al.  The margination propensity of spherical particles for vascular targeting in the microcirculation , 2008, Journal of nanobiotechnology.

[117]  Eric Pridgen,et al.  Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.

[118]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[119]  T. Ishida,et al.  Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes. , 2008, International journal of pharmaceutics.

[120]  J. Lewis,et al.  The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151. , 2008, Cancer cell.

[121]  S. Digumarthy,et al.  Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.

[122]  Taro Shimizu,et al.  PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[123]  Shaker A Mousa,et al.  The role of tissue factor pathway inhibitor in tumor growth and metastasis. , 2007, Seminars in thrombosis and hemostasis.

[124]  A. Varki.  Trousseau's syndrome: multiple definitions and multiple mechanisms. , 2007, Blood.

[125]  Hari Singh Nalwa,et al.  Nanotechnology and health safety--toxicity and risk assessments of nanostructured materials on human health. , 2007, Journal of nanoscience and nanotechnology.

[126]  Samir Mitragotri,et al.  Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[127]  Shaun P Jackson,et al.  The growing complexity of platelet aggregation. , 2007, Blood.

[128]  Kandaswamy Vijayan,et al.  Micelles of Different Morphologies—Advantages of Worm-like Filomicelles of PEO-PCL in Paclitaxel Delivery , 2007, Pharmaceutical Research.

[129]  Ronald Koschny,et al.  The promise of TRAIL—potential and risks of a novel anticancer therapy , 2007, Journal of Molecular Medicine.

[130]  E. V. Kulikova,et al.  Doxorubicin pharmacokinetics in lymphoma patients treated with doxorubicin-loaded eythrocytes. , 2007, Haematologica.

[131]  D. Discher,et al.  Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.

[132]  M Ferrari,et al.  The adhesive strength of non-spherical particles mediated by specific interactions. , 2006, Biomaterials.

[133]  A. Puisieux,et al.  Metastasis: a question of life or death , 2006, Nature Reviews Cancer.

[134]  Wen-chao Song,et al.  Membrane complement regulatory proteins. , 2006, Clinical immunology.

[135]  M. Prato,et al.  Applications of carbon nanotubes in drug delivery. , 2005, Current opinion in chemical biology.

[136]  H. Noguchi,et al.  Shape transitions of fluid vesicles and red blood cells in capillary flows. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[137]  K. Carpenter,et al.  Substituted carborane-appended water-soluble single-wall carbon nanotubes: new approach to boron neutron capture therapy drug delivery. , 2005, Journal of the American Chemical Society.

[138]  Lewis L Lanier,et al.  NK cell recognition. , 2005, Annual review of immunology.

[139]  J. Chow,et al.  MUC1 Mediates Transendothelial Migration in vitro by Ligating Endothelial Cell ICAM-1 , 2005, Clinical & Experimental Metastasis.

[140]  C. Rao,et al.  Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[141]  Tanja Fehm,et al.  Circulating Tumor Cells in Patients with Breast Cancer Dormancy , 2004, Clinical Cancer Research.

[142]  Jonathan W. Uhr,et al.  Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.

[143]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[144]  F. Ataullakhanov,et al.  Pharmacokinetics of erythrocyte-bound daunorubicin in patients with acute leukemia. , 2004, Medical science monitor : international medical journal of experimental and clinical research.

[145]  J. M. Lanao,et al.  Drug, enzyme and peptide delivery using erythrocytes as carriers. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[146]  L. Moretta,et al.  Unravelling natural killer cell function: triggering and inhibitory human NK receptors , 2004, The EMBO journal.

[147]  Ching-An Peng,et al.  Reduced Phagocytosis of Colloidal Carriers Using Soluble CD47 , 2003, Pharmaceutical Research.

[148]  P. Colombat,et al.  Improved pharmacodynamics of l-asparaginase-loaded in human red blood cells , 1996, European Journal of Clinical Pharmacology.

[149]  K. Ley.  The role of selectins in inflammation and disease. , 2003, Trends in molecular medicine.

[150]  T. Ishida,et al.  Accelerated clearance of PEGylated liposomes in rats after repeated injections. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[151]  P. Couvreur,et al.  Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.

[152]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.

[153]  F. Siddiqui,et al.  Tissue Factor Pathway Inhibitor Reduces Experimental Lung Metastasis of B16 Melanoma , 2002, Thrombosis and Haemostasis.

[154]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[155]  J. Wang,et al.  Human neutrophils facilitate tumor cell transendothelial migration. , 2001, American journal of physiology. Cell physiology.

[156]  Y. Sugiyama,et al.  Anti-metastatic effect of the sialyl Lewis-X analog GSC-150 on the human colon carcinoma derived cell line KM12-HX in the mouse. , 2001, Biological & pharmaceutical bulletin.

[157]  C. Lagenaur,et al.  Role of CD47 as a marker of self on red blood cells. , 2000, Science.

[158]  W. Oyen,et al.  Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. , 2000, The Journal of pharmacology and experimental therapeutics.

[159]  K. Schütze,et al.  Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. , 2000, The American journal of pathology.

[160]  B. Echtenacher,et al.  Lysis of tumor cells by natural killer cells in mice is impeded by platelets. , 1999, Cancer research.

[161]  F. Fahrenholz,et al.  A Laboratory Guide to Biotin-Labeling in Biomolecule Analysis , 2012, BioMethods.

[162]  L. Pilarski,et al.  The breast mucin MUCI as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer. , 1996, Cancer research.

[163]  V. Muzykantov.  Avidin/Biotin-Mediated Conjugation of Antibodies to Erythrocytes: An Approach for in vivo Immunoerythrocyte Exploration , 1996 .

[164]  M. Tonetti,et al.  Clinical efficacy and toxicity of doxorubicin encapsulated in glutaraldehyde-treated erythrocytes administered to dogs with lymphosarcoma. , 1994, American journal of veterinary research.

[165]  M. Laguerre,et al.  Erythrocytes as Carriers for L‐Asparaginase. Methodological and Mouse In‐vivo Studies , 1990, The Journal of pharmacy and pharmacology.

[166]  W. Satterfield,et al.  Intraperitoneal administration of carrier erythrocytes in dogs: an improved method for delivery of L‐asparaginase , 1990, Biotechnology and applied biochemistry.

[167]  E. Zocchi,et al.  Encapsulation of doxorubicin in liver-targeted erythrocytes increases the therapeutic index of the drug in a murine metastatic model. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[168]  D. Lewis,et al.  Therapeutic efficacy of asparaginase encapsulated in intact erythrocytes. , 1985, Biochemical pharmacology.

[169]  S. Updike,et al.  Infusion of red blood cell-loaded asparaginase in monkey. Immunologic, metabolic, and toxicologic consequences. , 1983, The Journal of laboratory and clinical medicine.

[170]  R H Glew,et al.  Enzyme loading of erythrocytes. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[171]  C. DeBarbosaN.  Therapy of cancer , 1957 .